tiprankstipranks
Trending News
More News >
Aptevo Therapeutics Inc (APVO)
NASDAQ:APVO
US Market

Aptevo Therapeutics (APVO) Income Statement

Compare
735 Followers

Aptevo Therapeutics Income Statement

Last quarter (Q3 2025), Aptevo Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Aptevo Therapeutics's net income was $-7.55M. See Aptevo Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 3.11M$ 12.29M$ 4.31M
Gross Profit
$ -352.00K$ 0.00$ 3.11M$ 12.29M$ -13.54M
Operating Expenses
$ 24.25M$ 28.88M$ 31.75M$ 33.69M$ 13.95M
Depreciation and Amortization
$ 352.00K$ 567.00K$ 901.00K$ 1.14M$ 1.31M
EBITDA
$ -23.78M$ -28.31M$ -27.74M$ -20.26M$ -26.19M
Operating Income
$ -24.60M$ -28.88M$ -28.64M$ -21.40M$ -27.49M
Other Income/Expenses
$ 472.00K$ 10.23M$ 35.66M$ -8.01M$ -3.43M
Pretax Income
$ -24.13M$ -18.65M$ 7.01M$ -29.41M$ -30.92M
Net Income
$ -24.13M$ -17.41M$ 8.03M$ -28.46M$ -17.75M
Per Share Metrics
Basic EPS
$ -1.75K$ -46.34K$ 51.24K$ -197.65K$ -308.11K
Diluted EPS
$ -1.75K$ -46.34K$ 51.22K$ -197.65K$ -308.11K
Weighted Average Shares Outstanding
13.81K----
Weighted Average Shares Outstanding (Diluted)
13.81K----
Currency in USD

Aptevo Therapeutics Earnings and Revenue History